Literature DB >> 12223456

Cures for the Third World's problems: the application of genomics to the diseases plaguing the developing world may have huge medical and economic benefits for those countries and might even prevent armed conflict.

Samuel Broder1, Stephen L Hoffman, Peter J Hotez.   

Abstract

Mesh：

Year:  2002        PMID： 12223456      PMCID： PMC1084240          DOI： 10.1093/embo-reports/kvf187

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  28 in total

1.  The stimulation of acquired immunity in dogs by injections of extracts of the esophagus of adult hookworms.

Authors:  R E THORSON
Journal:  J Parasitol       Date:  1956-10       Impact factor: 1.276

2.  Hookworm burden reductions in BALB/c mice vaccinated with recombinant Ancylostoma secreted proteins (ASPs) from Ancylostoma duodenale, Ancylostoma caninum and Necator americanus.

Authors:  L Sen; K Ghosh; Z Bin; S Qiang; M G Thompson; J M Hawdon; R A Koski; X Shuhua; P J Hotez
Journal:  Vaccine       Date:  2000-01-06       Impact factor: 3.641

Review 3.  Implications of the human genome for understanding human biology and medicine.

Authors:  G Subramanian; M D Adams; J C Venter; S Broder
Journal:  JAMA       Date:  2001-11-14       Impact factor: 56.272

Review 4.  Immunological genomics of Brugia malayi: filarial genes implicated in immune evasion and protective immunity.

Authors:  R M Maizels; M L Blaxter; A L Scott
Journal:  Parasite Immunol       Date:  2001-07       Impact factor: 2.280

Review 5.  Impact of Plasmodium falciparum malaria on performance and learning: review of the evidence.

Authors:  P A Holding; R W Snow
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

6.  Infectious disease. Research (genomics) is crucial to attacking malaria.

Authors:  S L Hoffman
Journal:  Science       Date:  2000-11-24       Impact factor: 47.728

Review 7.  Microbial disease in humans: A genomic perspective.

Authors:  G Subramanian; R Mural; S L Hoffman; J C Venter; S Broder
Journal:  Mol Diagn       Date:  2001-12

8.  Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.

Authors:  Stephen L Hoffman; Lucy M L Goh; Thomas C Luke; Imogene Schneider; Thong P Le; Denise L Doolan; John Sacci; Patricia de la Vega; Megan Dowler; Chris Paul; Daniel M Gordon; Jose A Stoute; L W Preston Church; Martha Sedegah; D Gray Heppner; W Ripley Ballou; Thomas L Richie
Journal:  J Infect Dis       Date:  2002-04-01       Impact factor: 5.226

Review 9.  Plasmodium, human and Anopheles genomics and malaria.

Authors:  Stephen L Hoffman; G Mani Subramanian; Frank H Collins; J Craig Venter
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

10.  A hookworm glycoprotein that inhibits neutrophil function is a ligand of the integrin CD11b/CD18.

Authors:  M Moyle; D L Foster; D E McGrath; S M Brown; Y Laroche; J De Meutter; P Stanssens; C A Bogowitz; V A Fried; J A Ely
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157
View more
  6 in total

1.  Neglected diseases: under-funded research and inadequate health interventions. Can we change this reality?

Authors:  Carlos M Morel
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

2.  Scientists for a better world.

Authors:  Emmanuel G Reynaud
Journal:  EMBO Rep       Date:  2005-02       Impact factor: 8.807

3.  Trypanocidal and leishmanicidal activities of sesquiterpene lactones from Ambrosia tenuifolia Sprengel (Asteraceae).

Authors:  Valeria P Sülsen; Fernanda M Frank; Silvia I Cazorla; Claudia A Anesini; Emilio L Malchiodi; Blanca Freixa; Roser Vila; Liliana V Muschietti; Virginia S Martino
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

Review 4.  The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic.

Authors:  Samuel Broder
Journal:  Antiviral Res       Date:  2009-12-16       Impact factor: 5.970

5.  Asthma in Africa.

Authors:  Matthias Wjst; Daniel Boakye
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

6.  Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application.

Authors:  Chengchao Ding; Darshit Patel; Yunjing Ma; Jamie F S Mann; Jianjun Wu; Yong Gao
Journal:  Front Immunol       Date:  2021-07-20       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.